Oncology-focused startup Beta Drugs raises Rs 117 Cr from HealthQuad and others

Quick Summary:

Beta Drugs offers a broad product portfolio across all major oncology segments, including chemotherapy, targeted, hormonal and supportive therapy.

Beta Drugs, which claims to be one of the few vertically integrated manufacturers in the country, was exclusively advised by o3 Capital during the transaction.

The round also witnessed participation from a Singapore-based investment fund and a private wealth management firm.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Akshita Toshniwal

Category: StartupsEconomyBusiness

Markets: IndiaSingapore

Topics: Vertically Healthquad Investment Drugs Privacy Beta Product Oncology Portfolio Policy Startup

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-27 @ 12:00:14 (10 hours ago)

News Timezone: GMT +8:00

News Source URL: yourstory.com

Language: English

Article Length: 237 words

Reading Time: 2 minutes read

Sentences: 16 lines

Sentence Length: 15 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © YourStory

News ID: 23905707

View Article Analysis

About YourStory

Main Topics: StartupsEconomyBusiness

Official Website: yourstory.com

Update Frequency: 29 posts per day

Year Established: 2008

Headquarters: India

News Last Updated: 8 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #44

Publisher Details

Frequently Asked Questions